ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma
Open Access
- 23 February 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (13) , 16910-16922
Abstract
ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinomaKeywords
This publication has 40 references indexed in Scilit:
- ISG15: leading a double life as a secreted moleculeExperimental & Molecular Medicine, 2013
- As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial–mesenchymal transition and activation of AKT signalingCarcinogenesis, 2012
- Host–tumor interactions in nasopharyngeal carcinomasSeminars in Cancer Biology, 2012
- Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?Cancer Research, 2012
- Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes MetastasisCancer Research, 2011
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cellsJournal of Clinical Investigation, 2009
- UBE1L causes lung cancer growth suppression by targeting cyclin D1Molecular Cancer Therapeutics, 2008
- The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancerBreast Cancer Research, 2008
- Identification of Cancer Stem Cell–Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell LineCancer Research, 2007
- The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe?☆Cytokine & Growth Factor Reviews, 2006